Drug development and approval are frightfully complex, expensive, and time-consuming. Making mountains of drug raises additional challenges. Working this process as a first-timer adds more complication. David will share an overview of drug development, policies supporting development of therapies for neglected or orphan diseases, and the challenges for developing a potentially life-saving drug.
Event Information
Event Topic:
Clinical Trials: “One Drug’s Journey” or “Orphans in the Wilderness”
Event Description:
Drug development and approval are frightfully complex, expensive, and time-consuming. Making mountains of drug raises additional challenges. Working this process as a first-timer adds more complication. David will share an overview of drug development, policies supporting development of therapies for neglected or orphan diseases, and the challenges for developing a potentially life-saving drug.
Date/Time:
Date(s) - 02/26/19
8:30 am - 10:15 am
Event Location:
NOVA - 505 West Olive Ave, Sunnyvale- Suite 799:
Speaker Information
Event Speaker:
David Larwood
Event Speaker Title:
CEO
Event Speaker Company:
Valley Fever Solutions
Event Speaker Bio:
David learned drug development in his PhD studies at UCSF in Pharmaceutical Chemistry, then pursued a career in patent law, then as a business executive with three very successful technology companies, including 5 years as General Counsel of a public company. Returning to the world of pharmaceuticals, for 11 years he has been leading development of NikZ with $7M support from the NIH. NikZ was recognized for its therapeutic potential in the 1980s. A key investigator led commercial development of NikZ at a mid sized pharma company until its pipeline collapsed, stranding NikZ. A leading Valley Fever clinician got help and guidance from the NIH to restart development. David appeared soon after, highly motivated to take on this development. They are now preparing to make the mountains of drug required for animal testing before proceeding with further tests in humans. This is personal for David. His father studied the disease for decades after Tom's friend and clinical partner led clinical trials for AmphotericinB to treat Valley Fever, the first drug that provided useful therapy, still in use 60 years later. David’s mother set up a foundation to develop a vaccine against Valley Fever and raised millions for this effort.
Event Details
Cost:
$0
Add To Calendar
